Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Lucy B. Palmer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Faculty Directed Research
Smaldone, G. (PI) & Palmer, L. B. (CoPI)
11/1/14 → 12/31/26
Project: Research
-
Ortho-McNeil: A Phase 2, Open-Label, Non-Comparative Study of Doripenem In The Treatment Of Nosocomial And Ventilator-Associated Pneumonia In Hospitals Where Pseudomonas Aeruginosa May Be A Prevalent Pathogen
Palmer, L. B. (CoPI), Smaldone, G. (CoPI), Richman, P. (PI), Baram, D. (CoPI), Daroowalla, F. (CoPI), Mallea, J. (CoPI), O'Riordan, T. (CoPI) & Strachan, P. (CoPI)
12/11/07 → 02/17/09
Project: Research
-
TARGETED ENDOBRONCHIAL AEROSOLIZED ANTIBIOTICS IN MECHANICALLY VENTILATED PATIENTS
Palmer, L. B. (PI) & Smaldone, G. (CoPI)
05/1/05 → 03/31/10
Project: Research
-
TARGETED ENDOBRONCHIAL AEROSOLIZED ANTIBIOTICS IN MECHANICALLY VENTILATED PATIENTS
Palmer, L. B. (PI)
04/24/04 → 04/30/06
Project: Research
-
TARGETED ENDOBRONCHIAL AEROSOLIZED ANTIBIOTICS IN MECHANICALLY VENTILATED PATIENTS
Palmer, L. B. (PI)
05/1/03 → 04/30/05
Project: Research
-
Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy
Palmer, L. B., Monteforte, M. & Smaldone, G. C., Jan 2025, In: British Journal of Clinical Pharmacology. 91, 1, p. 127-133 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?
Palmer, L. B. & Smaldone, G. C., Jan 2022, In: Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35, 1, p. 11-24 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access10 Scopus citations -
Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin (Intensive Care Medicine, (2020), 46, 4, (766-770), 10.1007/s00134-019-05890-w)
the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia, Apr 1 2020, In: Intensive Care Medicine. 46, 4, p. 832 1 p.Research output: Contribution to journal › Comment/debate
Open Access2 Scopus citations -
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia, Apr 1 2020, In: Intensive Care Medicine. 46, 4, p. 766-770 5 p.Research output: Contribution to journal › Article › peer-review
Open Access42 Scopus citations -
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials
Weiss, E., Zahar, J. R., Alder, J., Asehnoune, K., Bassetti, M., Bonten, M. J. M., Chastre, J., De Waele, J., Dimopoulos, G., Eggimann, P., Engelhardt, M., Ewig, S., Kollef, M., Lipman, J., Luna, C., Martin-Loeches, I., Pagani, L., Palmer, L. B., Papazian, L. & Poulakou, G. & 9 others, , Nov 13 2019, In: Clinical Infectious Diseases. 69, 11, p. 1912-1918 7 p.Research output: Contribution to journal › Article › peer-review
Open Access45 Scopus citations